New postmortem diagnostic biomarker for myocardial infarction: ischemia modified albumin

Yükleniyor...
Küçük Resim

Tarih

Dergi Başlığı

Dergi ISSN

Cilt Başlığı

Yayıncı

Taylor & Francis Ltd

Erişim Hakkı

info:eu-repo/semantics/closedAccess

Özet

We investigated the change of IMA levels as biochemical markers, especially in the postmortem diagnosis of early MI. Also, histological investigation has been performed in cases of cardiac deaths and in non-cardiac cases. To the best of our knowledge, this is the first study to investigate the levels of IMA in the postmortem diagnosis of early MI. A series of medicolegal autopsy cases (n=139; 6-24 h postmortem, with a median of 16 h) were examined at our institute. The cases comprised 112 males and 27 females, between 16 and 89 years of age. Subjects were divided into six groups depending upon their final cause of death according to medical data, autopsy reports, biochemical and histological findings. The groups were as follows: cardiovascular disease, blunt trauma, asphyxia, pathological cerebral hemorrhage, bleeding due to a sharp object and gunshot injuries, and poisoning. IMA levels in the cardiovascular disease group were found to be significantly higher than the blunt trauma, asphyxia, pathological cerebral hemorrhage, and bleeding groups (p < 0.05). It is known that after MI, if less than 4-6 hours pass before death, the histopathology of the heart does not reveal significant findings. Our results demonstrated that IMA might be a valid biochemical marker, especially in the postmortem diagnosis of early MI.

Açıklama

Anahtar Kelimeler

Myocardial infarction, ischemia modified albumin, postmortem biochemistry, diagnostic biomarker, forensic pathology, cause of death

Kaynak

Australian Journal of Forensic Sciences

WoS Q Değeri

Scopus Q Değeri

Cilt

51

Sayı

2

Künye

Onay

İnceleme

Ekleyen

Referans Veren